K

Kadimastem

45 employees

Kadimastem is a regenerative medicine company focused on the industrial development and commercialization of stem cell-based therapeutics.

Basic info

biotechnology research

Biotechnology

drug screening for myelin sheath

human oligodendrocytes

ALS

GMP facilities

bio-banking

human beta cells

cell therapy

cell production

Therapeutics

Clinicaltrials

DiabetesCURE

type 1 diabetes

stem cells

ALStreatment

2009

$3.2M

from 2 investors over 2 rounds

K

Kadimastem raised undisclosed on January 19, 2023

Investors: BIRD Foundation

K

Kadimastem raised $3.2M on November 25, 2021

Investors: ILEX MEDICAL LTD